Senior Director, Pipeline Market Access Strategy - Oncology

The Senior Director, Pipeline Market Access Strategy (PMAX) is a newly created role responsible for leading and inspiring the end-to-end global market access strategy for pipeline assets within their assigned Business Unit. The role bridges early asset development and future commercialization readiness, ensuring pricing and access considerations are embedded from the earliest stages of the drug development lifecycle through Phase 3 design and identification of evidence needs. The Senior Director will lead a team across US Pipeline Strategy and International Pipeline Strategy and will define distinct US and international strategies to optimize global launch success.

Responsibilities

Owns the end-to-end pipeline integrated access strategy for all pre-launch and development-stage assets within the assigned Business Unit; Serves as the primary voice of pipeline market access strategies at Business Unit governance forums; Serves as the voice of access into pipeline Business Development opportunities; Leads prioritization exercises across the pipeline portfolio; Creates and optimizes launch strategies including considerations for IRA, MFN, and other market forces; Defines and delivers the Access Roadmap; Partners with R&D and Regulatory teams to embed access-relevant endpoints, comparators, and trial design elements into clinical development programs; Defines and champions Target Product Profiles from a market access perspective; Generates and maintains global payer and HTA evidence requirements; Provides strategic leadership to the US Pipeline Strategy Lead and International Pipeline Strategy Lead; Aligns US payer strategy with international HTA, pricing, and reimbursement approaches; Leads cross-functional launch readiness reviews; Leads the development of Integrated Evidence Plans in collaboration with HEOR; Partners with Government Affairs on policy and reimbursement landscape; Works with Business Development on in-licensing, partnership, and acquisition opportunities; Serves as the access subject matter expert in due diligence processes; Builds, develops, and retains a high-performing pipeline access team

Requirements

Advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field; Bachelor's degree in a scientific, business, or public health discipline as a minimum baseline; A minimum of 12-15 years of progressive, senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical/biopharmaceutical function, with a substantial portion focused on pipeline and pre-launch strategy; Demonstrated expertise in global market access, including deep working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks across major international markets (US, EU5, Japan, and additional key markets); Proven experience shaping clinical development strategy from a market access and outcomes evidence perspective, including contributing to clinical trial design, endpoint selection, and Integrated Evidence Plan development with R&D teams; Strong track record of leading and developing high-performing teams in a matrixed, multinational environment; Ability to manage direct reports and influence cross-functional partners without direct authority; Comfortable operating at the senior leadership level and communicating complex access strategy to executive audiences; Deep expertise in at least one therapeutic area

Nice to have

Formal training or demonstrated expertise in health technology assessment (HTA), health economics, outcomes research, or pharmaceutical development; Experience supporting Business Development activities including asset due diligence, licensing evaluations, and access-based valuation assessments; Experience across multiple therapeutic areas (e.g., Oncology, Immunology, Neuroscience)

Benefits

Comprehensive package of benefits including paid time off (vacation, holidays, sick); Medical, dental, and vision insurance; 401(k) for eligible employees; Eligibility for long-term incentive programs